This page shows the latest Evotec news and features for those working in and with pharma, biotech and healthcare.
Evotec will oversee drug discovery and pre-clinical development, while Almirall will lead the clinical development and marketing. ... We are looking forward to leveraging the complementary expertise of Evotec and Almirall in order to develop promising
It remains firmly committed to women’s health however, and just last week added to its pipeline in this area by signing a five-year research alliance with Evotec focusing on ... The Evotec and Daré deals sandwiched two other agreements signed in the
There has been little progress in how these and other related conditions are diagnosed and treated, according to Evotec. ... Bayer and Evotec will both contribute drug targets to the alliance as well as other technology platforms, and will jointly
Evotec’s proprietary PanHunter bioinformatics drug discovery platform has already attracted a number of deals with big pharma and Celgene, among others. ... in nephrology clinical development and commercialisation,” said Cord Dohrmann, chief
Will challenge AstraZeneca and others in DNA damage response. German biotech Evotec has decided to bundle its cancer therapeutic programmes focused on DNA damage response (DDR) into a new spin-off ... virtual” spin out that will still have access to
This deal extends Exscientia’s list of partnerships with pharma and biotech companies, with existing collaborations involving Roche, GSK, Sanofi and Evotec.
More from news
Approximately 17 fully matching, plus 24 partially matching documents found.
The companies, Abbvie, Astex Pharmaceuticals, Eisai, Johnson &Johnson, Lilly, MSD and Takeda, Evotec and Charles River, participate in research projects alongside academic scientists.
We’ve also signed numerous major pharma collaborations with companies including Roche, Celgene, Sanofi, GSK and Evotec, estimated to be worth over $1bn in milestones and royalties.
Last month, Johnson &Johnson Innovation, Takeda and Evotec became the latest pharma research groups to join the initiative, alongside existing strategic partners AbbVie, Astex Pharmaceuticals, Eisai, Lilly and MSD. ... We’re excited to welcome Johnson
For example, Evotec, the German small molecule development company, is acquiring for $300m the US preclinical development company, Aptuit. ... 400. Aptuit (US). Evotec (DE). Company acquisition. Drug discovery and development to IND submission including
320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... upfront. And although the upfronts are a modest percentage of the headline figure, ranging from < 1% (BioInvent) to 15%
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
He has also served on several boards including Ablynx, Evotec and Acambis.
Cites health reasons. Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
According to Werner Lanthaler, CEO of Evotec AG (a long-time partner of Bayer AG, well-known for their role in advocating for women’s health) in an interview with In
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...